This is a review about RNA polymerase II, based on 61 published articles (read how Labome selects the articles), using RNA polymerase II antibody in all methods. It is aimed to help Labome visitors find the most suited RNA polymerase II antibody.
RNA polymerase II synonym: POLR2; POLRA; RPB1; RPBh1; RPO2; RPOL2; RpIILS; hRPB220; hsRPB1; DNA-directed RNA polymerase II largest subunit, RNA polymerase II 220 kd subunit; DNA-directed RNA polymerase II subunit A; DNA-directed RNA polymerase II subunit RPB1; DNA-directed RNA polymerase III largest subunit; RNA polymerase II subunit B1; RNA-directed RNA polymerase II subunit RPB1

Santa Cruz BiotechnologySanta Cruz Biotechnology RNA polymerase II product
  • ChIP assayIn 2011, Jing Ping Hsin et al. applied Santa Cruz Biotechnology RNA polymerase II antibody to perform western blot and ChIP assay in order to show that histone mRNA 3 end processing needs the phosphorylation of RNAP II CTD Thr4 [ncbi , more ]. In 2010, Tokameh Mahmoudi et al. utilized Santa Cruz Biotechnology RNA polymerase II antibody to perform ChIP assays in order to study the function of the leukemia-associated mllt10/af10-dot1l in intestinal homeostasis [ncbi , more ]. Moon Kyoo Jang et al. employed Santa Cruz Biotechnology RNA polymerase II antibody to perform ChIP assays in order to study the association between the papillomavirus E2 proteins, the host Brd4 protein and the transcriptionally active cellular genes [ncbi , more ] in 2009 and Laetitia Seguin et al. used Santa Cruz Biotechnology RNA polymerase II antibody to study the reguation of the expression of Ect2, MgcRacGAP, and MKLP1 during cell cycle progression (catalog: sc-899) [ncbi , more ]. Santa Cruz Biotechnology RNA polymerase II antibody was utilized in 2008 to perform CHIP assay in order to study how Myc represses gene transcription [ncbi , more ], to study the contribution of c-Jun to ccl2 transcriptional regulation in genetically modified mouse fibroblasts and in human cells (catalog: sc-899) [ncbi , more ], to study FoxA1 differential transcriptional activities in breast and prostate cancer cells and their functional relation with the epigenome of these cells [ncbi , more ], to study the molecular basis of CD4 regulation and provide a conceptual framework for understanding how the same regulatory elements can mediate both reversible and irreversible CD4 regulation [ncbi , more ], to study the recruitment of DOT1L and the patterning of mono-, di-, and trimethylation of H3K79 under dynamic conditions in human HEK293T cells (catalog: sc-899) [ncbi , more ], to demonstrate that a specific gene loop conformation is imposed on integrated HIV-1 provirus after transcriptional activation [ncbi , more ]and to study a different model, Poisson mixture model, within the same empirical Bayes framework for identifying gene targets with differential Pol II binding activities in breast cancer MCF7 cell line under various conditions (catalog: sc-899,sc-8005) [ncbi , more ]. Santa Cruz Biotechnology RNA polymerase II antibody was employed in 2007 to study the roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter [ncbi , more ], to identify novel functional TBP-binding sites and general factor repertoires (catalog: sc-899) [ncbi , more ]and to study the binding patterns of three members of the E2F family in five human cell types (catalog: sc-899) [ncbi , more ]. Santa Cruz Biotechnology RNA polymerase II antibody was applied in 2006 to determine whether the G-rich sequence promotes transcriptional pausing and consequent termination activity in HeLa cells [ncbi , more ], to demonstrate a widespread role for E2F1 in the human genome [ncbi , more ], to check the transcriptional activity of the p21 (waf1/cip1) promoter in MCF-7 human breast cancer cells (catalog: sc-13583) [ncbi , more ]and to study the role of IPS-1, IRF3, and IFN in Legionella infection of lung epithelium in human A549 cells [ncbi , more ]. Santa Cruz Biotechnology RNA polymerase II antibody was used in 2005 to study the role of DNA replication factor MCM5 in Stat1-mediated transcriptional activation [ncbi , more ], to investigate the IL-8 and IkappaBalpha gene regulatory regions in A549 human lung carcinoma cells (catalog: sc-899) [ncbi , more ], to study the control of endothelial nitric-oxide synthase expression (catalog: sc-899) [ncbi , more ], to study the coactivators and corepressors of NF-kappa B in I kappa B alpha gene promoter (catalog: sc-9001) [ncbi , more ], to indentify the human hyaluronan synthase 2 gene as a primary retinoic acid and epidermal growth factor responding gene (catalog: sc-899) [ncbi , more ]and to study the function of forkhead box M1 to regulate the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase (catalog: sc-899) [ncbi , more ]. Sarah E Aiyar et al. employed Santa Cruz Biotechnology RNA polymerase II antibody to examine the dynamic association of RNAPII with the ERalpha-responsive promoters in human T47D cells [ncbi , more ] in 2004 and G Brett Robb et al. used Santa Cruz Biotechnology RNA polymerase II antibody to study the role for antisense mRNA (sONE) in the post-transcriptional regulation of eNOS in human cell lines [ncbi , more ]. In 2002, Ying Zhang et al. used Santa Cruz Biotechnology RNA polymerase II antibody to study transcriptional regulation of human luteinizing hormone receptor gene [ncbi , more ].
  • immunoprecipitationIn 2009, Chia Hsin Su et al. applied Santa Cruz Biotechnology RNA polymerase II antibody to perform immunoprecipitation in order to demonstrate that physical barrier due to the folding of chromatin in domain II can give rise to the depletion of RNA polymerase II [ncbi , more ]. In 2003, Joe F Lau et al. employed Santa Cruz Biotechnology RNA polymerase II antibody to study interferon (IFN) induced signal transduction and transcription activation complex [ncbi , more ].
  • western blotJing Ping Hsin et al. applied Santa Cruz Biotechnology RNA polymerase II antibody to perform western blot and ChIP assay in order to show that histone mRNA 3 end processing needs the phosphorylation of RNAP II CTD Thr4 [ncbi , more ] in 2011 and Carrie Bernecky et al. used Santa Cruz Biotechnology RNA polymerase II antibody to perform western blot in order to study mechanism of human Mediator-RNA polymerase II-TFIIF assembly (catalog: sc-899) [ncbi , more ]. In 2009, Bo Huang et al. utilized Santa Cruz Biotechnology RNA polymerase II antibody to introduce Brd4 as a coactivator of NF-kappa B via specific binding to acetylated RelA [ncbi , more ]. Zhiqiang Zhang et al. used Santa Cruz Biotechnology RNA polymerase II antibody to study the role of transcription termination factor Pcf11 on the processivity of Pol II (catalog: sc-899) [ncbi , more ] in 2007 and Victoria H Cowling et al. used Santa Cruz Biotechnology RNA polymerase II antibody to isolate CAK from human 293 cells and rat c-myc null fibroblasts (HO15.19 cells), and in western blot to detect CDK7 in rat TGR cells, rat c-myc null fibroblasts (HO15.19 cells), Tet-21/N cells and the immortalized mammary epithelial cells (IMECs) [ncbi , more ]. In 2006, Nancy L Vogel et al. applied Santa Cruz Biotechnology RNA polymerase II antibody to demonstrate that SSAT2 functions as a transcriptional coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance TNFalpha-induced NF-kappaB activity [ncbi , more ]. In 2005, Tessy Iype et al. used Santa Cruz Biotechnology RNA polymerase II antibody to determine the mechanism underlying regulation of the insulin gene by Pdx-1 [ncbi , more ]. In 2003, Joe F Lau et al. employed Santa Cruz Biotechnology RNA polymerase II antibody to study interferon (IFN) induced signal transduction and transcription activation complex [ncbi , more ]. In 2002, Janeen H Trembley et al. employed Santa Cruz Biotechnology RNA polymerase II antibody to study the important function of PITSLRE protein kinases in a signaling pathway that potentially regulates or links transcription and RNA processing events [ncbi , more ].
EMD MilliporeEMD Millipore RNA polymerase II product
  • ChIP assayIn 2009, Francesca Corlazzoli et al. utilized EMD Millipore RNA polymerase II antibody to test whether derangement of a factor upstream of RARalpha can triggers the repression of a pleiotropic epigenetic network [ncbi , more ]. In 2005, Mathilde Calligé et al. applied EMD Millipore RNA polymerase II antibody to study the contribution of CSN5/Jab1 to ERalpha ligand-dependent degradation and the mechanism of transcription activation in response to estradiol [ncbi , more ].
  • immunocytochemistryIn 2011, Robert J Sims et al. employed EMD Millipore RNA polymerase II antibody to perform immunocytochemistry in order to reveal that methylation of the carboxy-terminal domain of RNA polymerase II facilitates the expression of some RNAs (catalog: 05-623) [ncbi , more ].
  • immunoprecipitationIn 2009, Deliang Guo et al. utilized EMD Millipore RNA polymerase II antibody to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR (catalog: 05-623) [ncbi , more ]. In 2005, Christopher C Valley et al. used EMD Millipore RNA polymerase II antibody to investigate the regulation of ER alpha proteolysis and transcription [ncbi , more ].
  • western blotIn 2009, Asma Amleh et al. applied EMD Millipore RNA polymerase II antibody to investigate the role of BRCA1 in the regulation of early embryogenesis [ncbi , more ].
AbcamAbcam RNA polymerase II product
  • ChIP assayIn 2009, Niresh Hariparsad et al. applied Abcam RNA polymerase II antibody to perform ChIP assays in order to study the roles of PXR in the regulations of CYP4F12 and the coactivation and corepression to a broad range of promoters [ncbi , more ]. In 2008, Mathieu Lupien et al. utilized Abcam RNA polymerase II antibody to study FoxA1 differential transcriptional activities in breast and prostate cancer cells and their functional relation with the epigenome of these cells [ncbi , more ].
  • immunocytochemistryIn 2005, Reet Kurg et al. applied Abcam RNA polymerase II antibody to perform immunocytochemistry and western blot in order to study the interaction between E2 protein and structures in the nucleus. [ncbi , more ].
  • immunoprecipitationIn 2007, Imke Listerman et al. utilized Abcam RNA polymerase II antibody to study the effect of RNA polymerase II extragenic accumulation on transcription by RNA polymerase III [ncbi , more ]. In 2004, Andrea Újvári et al. used Abcam RNA polymerase II antibody to isolate Rpb1 from HeLa cell extracts, and in western blot to detect the presence of RNA polymerase II in U2AF65 immunoprecipitates in HeLa [ncbi , more ].
  • western blotIn 2005, Reet Kurg et al. applied Abcam RNA polymerase II antibody to perform immunocytochemistry and western blot in order to study the interaction between E2 protein and structures in the nucleus. [ncbi , more ]. In 2004, Andrea Újvári et al. used Abcam RNA polymerase II antibody to isolate Rpb1 from HeLa cell extracts, and in western blot to detect the presence of RNA polymerase II in U2AF65 immunoprecipitates in HeLa [ncbi , more ].
Sigma-AldrichSigma-Aldrich RNA polymerase II product
  • immunoprecipitationIn 2008, Jinhong Chang et al. employed Sigma-Aldrich RNA polymerase II antibody to examine the associations between Pol II and HDV RNAs [ncbi , more ].
BERKLEY ANTIBODY
  • western blotIn 2006, Jackie A Fretz et al. utilized RNA polymerase II antibody to demonstrate that 1, 25- (OH) 2D3 can enhance the expression of a critical component of the Wnt signaling pathway that is known to impact osteogenesis [ncbi , more ].
M VIGNERON (INSTITUTE OF GENETICS AND MOLECULAR AND CELL BIOLOGY)
  • western blotIn 2002, Beata Fuchsova et al. used RNA polymerase II antibody to study the role of nuclear dna helicase II in IFN-alpha activated transcription sites at PML nuclear bodies [ncbi , more ].
IGBMC
  • ChIP assayIn 2011, Satoru Hashimoto et al. employed RNA polymerase II antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ].
  • western blotIn 2011, Satoru Hashimoto et al. employed RNA polymerase II antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ].
Covance
  • ChIP assayIn 2011, Satoru Hashimoto et al. employed Covance RNA polymerase II antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ]. In 2010, Tokameh Mahmoudi et al. utilized Covance RNA polymerase II antibody to perform ChIP assays in order to study the function of the leukemia-associated mllt10/af10-dot1l in intestinal homeostasis [ncbi , more ]. Gloria Mas et al. applied Covance RNA polymerase II antibody to assay carry out chromatin immunoprecipitation assays in order to investigate the role for Hog1-mediated recruitment of RSC complex in nucleosome organization of stress-responsive loci [ncbi , more ] in 2009 and Moon Kyoo Jang et al. used Covance RNA polymerase II antibody to perform ChIP assays in order to study the association between the papillomavirus E2 proteins, the host Brd4 protein and the transcriptionally active cellular genes [ncbi , more ]. Covance RNA polymerase II antibody was employed in 2008 to develop a novel method for constructing a sheet of human corneal endothelial cells (HCECs) and examine the properties of the HCEC sheet [ncbi , more ], to demonstrate that a specific gene loop conformation is imposed on integrated HIV-1 provirus after transcriptional activation [ncbi , more ], to study the role of proximal D1 region in the regulation of RANKL gene expression [ncbi , more ]and to perform ChIP assays in order to study the association between ING4 and the activity of NF-kappa B molecules bound with target gene promoters [ncbi , more ]. In 2005, Jason E Fish et al. applied Covance RNA polymerase II antibody to study the control of endothelial nitric-oxide synthase expression [ncbi , more ].
  • immunocytochemistryIn 2007, Waltraud G Müller et al. used Covance RNA polymerase II antibody to perform immunocytochemistry assays in order to study a new domain of decondensed chromatin and its histone modification process surrounding transcription factories [ncbi , more ]. In 2005, Irina Lassot et al. applied Covance RNA polymerase II antibody to demonstrate p300 modulating ATF4 stability and transcriptional activity independently of its acetyltransferase domain [ncbi , more ]. In 2003, Flavia A O'Rourke et al. utilized Covance RNA polymerase II antibody to study the role of CHERP in cell proliferation in Jurkat T-lymphocytes [ncbi , more ].
  • immunoprecipitationIn 2011, Yehuda Brody et al. employed Covance RNA polymerase II antibody to perform immunoprecipitation in order to study the elongation funtion of RNA Polymerase II during co-transcriptional splicing [ncbi , more ]. Jason Matthews et al. employed Covance RNA polymerase II antibody to study aryl hydrocarbon receptor-mediated transcription in MCF-7 human breast carcinoma, T47D breast carcinoma cells, and HuH7 human liver carcinoma cells [ncbi , more ] in 2005 and Dominique Y Begon et al. used Covance RNA polymerase II antibody to study ERBB2 gene expression in mammary cancer cells [ncbi , more ].
  • western blotIn 2011, Satoru Hashimoto et al. employed Covance RNA polymerase II antibody to perform ChIP assay and western blot in order to show that immediate early gene expression is disrupted by MED23 mutation and results in intellectual disability [ncbi , more ]. In 2001, M Zhou et al. used Covance RNA polymerase II antibody to study CDK9 phosphorylation during human immunodeficiency virus type 1 transcription [ncbi , more ].
neoclone
  • immunoprecipitationIn 2007, Imke Listerman et al. utilized neoclone RNA polymerase II antibody to study the effect of RNA polymerase II extragenic accumulation on transcription by RNA polymerase III [ncbi , more ].
Articles Reviewed
  1. Jing Ping Hsin et al. (2011). "RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3' end processing".PMID 22053051
  2. Satoru Hashimoto et al. (2011). "MED23 mutation links intellectual disability to dysregulation of immediate early gene expression".PMID 21868677
  3. Carrie Bernecky et al. (2011). "Molecular architecture of the human Mediator-RNA polymerase II-TFIIF assembly".PMID 21468301
  4. Robert J Sims et al. (2011). "The C-terminal domain of RNA polymerase II is modified by site-specific methylation".PMID 21454787
  5. Yehuda Brody et al. (2011). "The in vivo kinetics of RNA polymerase II elongation during co-transcriptional splicing".PMID 21264352
  6. Tokameh Mahmoudi et al. (2010). "The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis".PMID 21103407
  7. Deliang Guo et al. (2009). "EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy".PMID 20009104
  8. Asma Amleh et al. (2009). "Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis".PMID 19340312
  9. Francesca Corlazzoli et al. (2009). "Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network".PMID 19173001
  10. Gloria Mas et al. (2009). "Recruitment of a chromatin remodelling complex by the Hog1 MAP kinase to stress genes".PMID 19153600
  11. Moon Kyoo Jang et al. (2009). "Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin".PMID 19129460
  12. Niresh Hariparsad et al. (2009). "Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes".PMID 19129222
  13. Bo Huang et al. (2009). "Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA".PMID 19103749
  14. Laetitia Seguin et al. (2009). "CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase".PMID 19015243
  15. Chia Hsin Su et al. (2009). "p53 chromatin epigenetic domain organization and p53 transcription".PMID 18936172
  16. Weixing Feng et al. (2008). "A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technology".PMID 18831789
  17. Susan Nozell et al. (2008). "The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes".PMID 18779315
  18. John F Kurland et al. (2008). "Myc-mediated transcriptional repression by recruitment of histone deacetylase".PMID 18483244
  19. Sabine Wolter et al. (2008). "c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene".PMID 18443042
  20. Mathieu Lupien et al. (2008). "FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription".PMID 18358809
  21. Ming Yu et al. (2008). "Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during T cell development".PMID 18322012
  22. David J Steger et al. (2008). "DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells".PMID 18285465
  23. Julian M Rozenberg et al. (2008). "All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues".PMID 18252004
  24. Kelly J Perkins et al. (2008). "Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals".PMID 18206969
  25. Robert D Nerenz et al. (2008). "An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3".PMID 18202151
  26. Imke Listerman et al. (2007). "Extragenic accumulation of RNA polymerase II enhances transcription by RNA polymerase III".PMID 18039033
  27. Jinhong Chang et al. (2008). "Transcription of hepatitis delta virus RNA by RNA polymerase II".PMID 18032511
  28. Xiaoqin Xu et al. (2007). "A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members".PMID 17908821
  29. Zhiqiang Zhang et al. (2007). "Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression".PMID 17606639
  30. Waltraud G Müller et al. (2007). "Organization of chromatin and histone modifications at a transcription site".PMID 17576795
  31. Antonella De Luca et al. (2007). "Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter".PMID 17519015
  32. Sergey Denissov et al. (2007). "Identification of novel functional TBP-binding sites and general factor repertoires".PMID 17268553
  33. Victoria H Cowling et al. (2007). "The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding".PMID 17242204
  34. Nancy L Vogel et al. (2006). "Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription".PMID 17011643
  35. Bastian Opitz et al. (2006). "Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication".PMID 16984921
  36. Natalia Gromak et al. (2006). "Pause sites promote transcriptional termination of mammalian RNA polymerase II".PMID 16648491
  37. Jackie A Fretz et al. (2006). "1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription".PMID 16613987
  38. Mark Bieda et al. (2006). "Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome".PMID 16606705
  39. Anna Saramaki et al. (2006). "Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor".PMID 16434701
  40. I Ching Wang et al. (2005). "Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase".PMID 16314512
  41. Irina Lassot et al. (2005). "p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain".PMID 16219772
  42. Marylynn Snyder et al. (2005). "The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation".PMID 16199513
  43. Reet Kurg et al. (2005). "Association of bovine papillomavirus E2 protein with nuclear structures in vivo".PMID 16051845
  44. Christopher C Valley et al. (2005). "Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus".PMID 15964799
  45. Jason Matthews et al. (2005). "Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters".PMID 15964790
  46. Mathilde Calligé et al. (2005). "CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome".PMID 15899841
  47. Hans F Luecke et al. (2005). "The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression".PMID 15879558
  48. Jason E Fish et al. (2005). "The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code".PMID 15870070
  49. Dominique Y Begon et al. (2005). "Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells".PMID 15870067
  50. Zhanguo Gao et al. (2005). "Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter".PMID 15811852
  51. Tessy Iype et al. (2005). "Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes".PMID 15743769
  52. Katri Saavalainen et al. (2005). "The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene".PMID 15722343
  53. Andrea Újvári et al. (2004). "Newly Initiated RNA encounters a factor involved in splicing immediately upon emerging from within RNA polymerase II".PMID 15377657
  54. Sarah E Aiyar et al. (2004). "Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor".PMID 15342491
  55. G Brett Robb et al. (2004). "Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript".PMID 15234981
  56. Flavia A O'Rourke et al. (2003). "Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes".PMID 12656674
  57. Joe F Lau et al. (2003). "Role of metazoan mediator proteins in interferon-responsive transcription".PMID 12509459
  58. Beata Fuchsova et al. (2002). "Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies".PMID 12163469
  59. Ying Zhang et al. (2002). "Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex".PMID 12091390
  60. Janeen H Trembley et al. (2002). "PITSLRE p110 protein kinases associate with transcription complexes and affect their activity".PMID 11709559
  61. M Zhou et al. (2001). "TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription".PMID 11572868